לוסרטאן טבע 12.5 מג
teva pharmaceutical industries ltd, israel - losartan potassium - טבליות מצופות פילם - losartan potassium 12.5 mg - losartan
לוסרטאן טבע 50 מג
teva pharmaceutical industries ltd, israel - losartan potassium - טבליות מצופות פילם - losartan potassium 50 mg - losartan
דולפאק 10 וטרינרי
eliezer linevitz ltd. - oxantel as embonate; praziquantel; pyrantel embonate - טבליה - oxantel as embonate 200.28 mg; pyrantel embonate 49.94 mg; praziquantel 50 mg - for curative treatment of dogs harbouring mixed parasitic infestations with the following adult stages of nematodes and cestode species : nemtodes : toxocara canis toxocaris leonine ancylostoma caninum uncinaria stenocephala trichuris vulpis. cestodes : dipylidum caninum taenia spp.
דולפאק 25 וטרינרי
eliezer linevitz ltd. - oxantel as embonate; praziquantel; pyrantel embonate - טבליה - oxantel as embonate 500.7 mg; pyrantel embonate 124.85 mg; praziquantel 125 mg - for curative treatment of dogs harbouring mixed parasitic infestations with the following adult stages of nematodes and cestode species : nemtodes : toxocara canis toxocaris leonine ancylostoma caninum uncinaria stenocephala trichuris vulpis. cestodes : dipylidum caninum taenia spp.
טיאסר 50 מ"ג
bioavenir ltd - losartan as potassium 50 mg - tablets - losartan - hypertension: losartan is indicated for the treatment of heart failure ( nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to tiasar is not recommended. renal protection in type - 2 diabetic patients with proteinuria: losartan is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease ( need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrphy. losartan is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventricular hypertrphy. the benefit of tiasar on the primary deposite end poin
טיאסר 100 מ"ג
bioavenir ltd - losartan as potassium 100 mg - tablets - losartan - hypertension: losartan is indicated for the treatment of heart failure ( nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to tiasar is not recommended. renal protection in type - 2 diabetic patients with proteinuria: losartan is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease ( need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrphy. losartan is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventricular hypertrphy. the benefit of tiasar on the primary deposite end poin
אמבוטייפ וטרינרי
eliezer linevitz ltd. - pyrantel embonate - פסטה - pyrantel embonate 11.4 g/dose
דואוטק וטרינרי
comex ltd - closantel as sodium; oxfendazole - תרחיף - oxfendazole 2.5 %w/v; closantel as sodium 5 %w/v
לוטן פלוס
unipharm ltd, israel - hydrochlorothiazide; losartan potassium - טבליה - losartan potassium 50 mg; hydrochlorothiazide 12.5 mg
לוטן פלוס
unipharm ltd, israel - hydrochlorothiazide; losartan potassium - טבליה - losartan potassium 50 mg; hydrochlorothiazide 12.5 mg